Journal Mobile Options
Table of Contents
Vol. 65, Suppl. 3, 2006
Issue release date: April 2006
Horm Res 2006;65:34–40
(DOI:10.1159/000091504)

Genetic Variations and Normal Fetal Growth

Dunger D.B. · Petry C.J. · Ong K.K.
Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Size at birth is said to be a highly heritable trait, with an estimated 30–70% of the variability a result of genetics. Data from family studies may be confounded, however, by potential interactions between fetal genes and the maternal uterine environment. Overall, the maternal environment tends to restrain fetal growth, and this is most evident in first pregnancies. Restraint of fetal growth appears to be inherited through the maternal line. Potential genetic candidates include the mitochondrial DNA 16189 variant, and common variants of exclusively maternally expressed genes, such as H19, which have been associated with size at birth. Maternal blood glucose levels and blood pressure are also correlated with size at birth, but the degree to which these changes relate to genetic variation in the mother is unclear. Elegant studies in mouse knockout models and rare genetic variants in humans have highlighted the importance of insulin-like growth factor I (IGF-I), IGF-II, insulin and their respective receptors in determining fetal growth. However, data linking common variation in the genes that regulate these proteins and receptors with size at birth are few and inconsistent. Interestingly, common variation in the insulin gene (INS) variable number tandem repeats, which regulates the transcription of insulin and IGF-II, has been associated with size at birth, largely in second and subsequent pregnancies, where maternal restraint is least evident. This suggests that fetal genes, and in particular paternally expressed genes, may have significant effects on fetal growth during pregnancies where maternal restraint of fetal growth is less evident.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Magnus P: Causes of variation in birth weight: a study of offspring of twins. Clin Genet 1984;25:15–24.
  2. Little RE, Sing CF: Genetic and environmental influences on human birth weight. Am J Hum Genet 1987;40:512–526.
  3. Ounsted M, Scott A, Moar VA: Constrained and unconstrained fetal growth: associations with some biological and pathological factors. Ann Hum Biol 1988;15:119–129.
  4. Ong KK, Preece MA, Emmett PM, Ahmed ML, Dunger DB: Size at birth and early childhood growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort study and analysis. Pediatr Res 2002;52:863–867.
  5. Karn MN, Penrose LS: Birth weight and gestation time in relation to maternal age, parity and infant survival. Ann Eugen 1951;16:147–164.
  6. Alberman E: Are our babies becoming bigger? J R Soc Med 1991;84:257–260.
  7. Gluckman PD, Breier BH, Oliver M, Harding J, Bassett N: Fetal growth in late gestation – a constrained pattern of growth. Acta Paediatr Scand Suppl 1990;367:105–110.
  8. Moore VM, Davies MJ, Willson KJ, Worsley A, Robinson JS: Dietary composition of pregnant women is related to size of the baby at birth. J Nutr 2004;134:1820–1826.
  9. Mathews F, Yudkin P, Neil A: Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ 1999;319:339–343.
  10. Innes KE, Byers TE, Marshall JA, Baron A, Orleans M, Hamman RF: Association of a woman’s own birth weight with her subsequent risk for pregnancy-induced hypertension. Am J Epidemiol 2003;158:861–870.
  11. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S: Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998;19:268–270.
  12. Weedon MN, Frayling TM, Shields B, Knight B, Turner T, Metcalf BS, Voss L, Wilkin TJ, McCarthy A, Ben-Shlomo Y, Davey Smith G, Ring S, Jones R, Golding J, Byberg L, Mann V, Axelsson T, Syvanen AC, Leon D, Hattersley AT: Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes 2005;54:576–581.
  13. Innes KE, Byers TE, Marshall JA, Baron A, Orleans M, Hamman RF: Association of a woman’s own birth weight with subsequent risk for gestational diabetes. JAMA 2002;287:2534–2541.
  14. Casteels K, Ong K, Phillips D, Bendall H, Pembrey M: Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1999;353:1499–1500.
  15. Reik W, Walter J: Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001;2:21–32.
  16. Haig D: Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol 1996;35:226–232.
  17. Ludwig T, Eggenschwiler J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A: Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996;177:517–535.
  18. Petry CJ, Ong KK, Barratt BJ, Wingate D, Cordell HJ, Ring SM, Pembrey ME, Reik W, Todd JA, Dunger DB: Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet 2005;6:22.
  19. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945–948.
  20. Sibley CP, Coan PM, Ferguson-Smith AC, Dean W, Hughes J, Smith P, Reik W, Burton GJ, Fowden AL, Constancia M: Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci USA 2004;101:8204–8208.
  21. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73–82.
  22. Ogilvy-Stuart AL, Soos MA, Hands SJ, Anthony MY, Dunger DB, O’Rahilly S: Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors. J Clin Endocrinol Metab 2001;86:3319–3326.
  23. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363–1367.
  24. Bonapace G, Concolino D, Formicola S, Strisciuglio P: A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 2003;40:913–917.
  25. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003;349:2211–2222.
  26. Okubo Y, Siddle K, Firth H, O’Rahilly S, Wilson LC, Willatt L, Fukushima T, Takahashi S, Petry CJ, Saukkonen T, Stanhope R, Dunger DB: Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 2003;88:5981–5988.
  27. Wutz A, Smrzka OW, Barlow DP: Making sense of imprinting the mouse and human IGF2R loci. Novartis Found Symp 1998;214:251–259.
  28. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE: Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med 1996;2:311–316.
  29. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le Bouc Y: Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005;37:1003–1007.
  30. Ong K, Kratzsch J, Kiess W, Dunger D: Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87:1041–1044.
  31. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB: Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550–3557.
  32. Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D: Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 2000;85:4266–4269.
  33. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002;359:1036–1037.
  34. Johnston LB, Dahlgren J, Leger J, Gelander L, Savage MO, Czernichow P, Wikland KA, Clark AJ: Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003;88:4805–4810.
  35. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y: A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 2002;51:2313–2316.
  36. Petry CJ, Ong KK, Wingate DL, Brown J, Scott CD, Jones EY, Pembrey ME, Dunger DB, Alspac Study Team: Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Horm IGF Res 2005;15:363–368.
  37. Gaunt TR, Cooper JA, Miller GJ, Day IN, O’Dell SD: Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001;10:1491–1501.
  38. Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA: IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996;9:415–421.
  39. Paquette J, Giannoukakis N, Polychronakos C, Vafiadis P, Deal C: The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem 1998;273:14158–14164.
  40. Dunger DB, Ong KK, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, Golding J, Pembrey ME, Ring S, Bennett ST, Todd JA: Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat Genet 1998;19:98–100.
  41. Ong KK, Petry CJ, Barratt BJ, Ring S, Cordell HJ, Wingate DL, Pembrey ME, Todd JA, Dunger DB: Maternal-fetal interactions and birth order influence insulin variable number of tandem repeats allele class associations with head size at birth and childhood weight gain. Diabetes 2004;53:1128–1133.
  42. Lindsay RS, Hanson RL, Wiedrich C, Knowler WC, Bennett PH, Baier LJ: The insulin gene variable number tandem repeat class I/III polymorphism is in linkage disequilibrium with birth weight but not Type 2 diabetes in the Pima population. Diabetes 2003;52:187–193.
  43. Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Taponen S, Hartikainen AL, King VJ, Elliott P, Jarvelin MR, McCarthy MI: Variation at the insulin gene VNTR (variable number tandem repeat) polymorphism and early growth: studies in a large Finnish birth cohort. Diabetes 2004;53:2126–2131.
  44. Mitchell SM, Hattersley AT, Knight B, Turner T, Metcalf BS, Voss LD, Davies D, McCarthy A, Wilkin TJ, Smith GD, Ben-Shlomo Y, Frayling TM: Lack of support for a role of the insulin gene variable number of tandem repeats minisatellite (INS-VNTR) locus in fetal growth or type 2 diabetes-related intermediate traits in United Kingdom populations. J Clin Endocrinol Metab 2004;89:310–317.
  45. Mason S, Ong KK, Pembrey ME, Woods KA, Dunger DB: The Gly972Arg variant in insulin receptor substrate-1 is not associated with birth weight in contemporary English children. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Diabetologia 2000;43:1201–1202.
  46. Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, Kultursay N: The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum Dev 2004;78:95–103.
  47. Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H: Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 2000;355:1241–1242.
  48. Zhang XQ, Varner M, Dizon-Townson D, Song F, Ward K: A molecular variant of angiotensinogen is associated with idiopathic intrauterine growth restriction. Obstet Gynecol 2003;101:237–242.
  49. Nishigori H, Tomura H, Tonooka N, Kanamori M, Yamada S, Sho K, Inoue I, Kikuchi N, Onigata K, Kojima I, Kohama T, Yamagata K, Yang Q, Matsuzawa Y, Miki T, Seino S, Kim MY, Choi HS, Lee YK, Moore DD, Takeda J: Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci USA 2001;98:575–580.
  50. Gloria-Bottini F, Lucarini N, Palmarino R, La Torre M, Nicotra M, Borgiani P, Cosmi E, Bottini E: Phosphoglucomutase genetic polymorphism of newborns. Am J Hum Biol 2001;13:9–14.
  51. Lorentzon M, Lorentzon R, Nordstrom P: Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy caucasian men: a cross-sectional and longitudinal study. J Clin Endocrinol Metab 2000;85:1666–1670.
  52. Karvonen MK, Koulu M, Pesonen U, Uusitupa MI, Tammi A, Viikari J, Simell O, Ronnemaa T: Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab 2000;85:1455–1460.
  53. Amante A, Gloria-Bottini F, Bottini E: Intrauterine growth: association with acid phosphatase genetic polymorphism. J Perinat Med 1990;18:275–282.
  54. Magrini A, Bottini N, Gloria-Bottini F, Stefanini L, Bergamaschi A, Cosmi E, Bottini E: Enzyme polymorphisms, smoking, and human reproduction. A study of human placental alkaline phosphatase. Am J Hum Biol 2003;15:781–785.
  55. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X: Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195–202.
  56. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE: Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 2004;117:26–31.
  57. Masuda K, Osada H, Iitsuka Y, Seki K, Sekiya S: Positive association of maternal G protein beta3 subunit 825T allele with reduced head circumference at birth. Pediatr Res 2002;52:687–691.
  58. Dunger DB, Ong KK: Endocrine and metabolic consequences of intrauterine growth retardation. Endocrinol Metab Clin North Am 2005;34:597–615.
  59. Hattersley AT, Tooke JE: The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999;353:1789–1792.
  60. Cianfarani S, Germani D, Branca F: Low birthweight and adult insulin resistance: the ‘catch-up growth’ hypothesis. Arch Dis Child Fetal Neonatal Ed 1999;81:F71–F73.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50